WallStSmart
NVO

Novo Nordisk A/S

NYSE: NVO · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$42.22
+4.79% today

Updated 2026-04-30

Market cap
$182.60B
P/E ratio
11.40
P/S ratio
0.59x
EPS (TTM)
$3.61
Dividend yield
4.38%
52W range
$35 – $78
Volume
21.0M

Novo Nordisk A/S (NVO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$7.74B$10.00B$12.90B$15.38B$19.68B$21.37B$22.21B$25.94B$31.69B$38.29B$48.31B$41.17B$44.62B$46.78B$51.95B$55.00B$78.89B$108.91B$120.97B$119.10B
Capital expenditures$3.32B$2.43B$2.04B$3.06B$3.90B$3.33B$3.62B$3.64B$4.33B$6.41B$8.27B$8.65B$12.41B$11.23B$22.08B$7.38B$14.75B$38.90B$51.31B$90.11B
Depreciation
Stock-based comp$308.00M$409.00M$371.00M$442.00M$368.00M$292.00M$414.00M$363.00M$823.00M$1.04B$1.54B$2.15B$2.29B
Free cash flow$4.42B$7.57B$10.85B$12.31B$15.78B$18.04B$18.59B$22.30B$27.36B$31.88B$40.05B$32.52B$32.21B$35.55B$29.87B$47.62B$64.13B$70.01B$69.66B$28.99B
Investing cash flow
Financing cash flow
Dividends paid$1.94B$2.22B$2.80B$703.17M$4.40B$5.70B$7.74B$9.71B$11.87B$12.90B$23.83B$18.84B$19.05B$19.41B$20.12B$21.52B$25.30B$31.77B$44.14B$51.76B
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00